Search results
How traffic noise hurts children's brains
BBC News· 2 hours agoAs awareness grows of the toll noise has on children's health and learning, some cities show the way to quieter roads and classrooms. In a New York...
OpenAI acquires Rockset to strengthen its retrieval capabilities
VentureBeat· 2 days agoDon’t miss OpenAI, Chevron, Nvidia, Kaiser Permanente, and Capital One leaders only at VentureBeat...
ETH-USD news: Consensys confirms major Ethereum win from SEC | Invezz ETH-USD news: Consensys...
Invezz· 4 days agoEthereum bulls, rejoice: Consensys brings good news about the cryptocurrency – and it’s from the...
Bloomberg Law Launches Six New In Focus Resources
Morningstar· 6 days agoBloomberg Law today announced multiple new In Focus resources highlighting emerging topics in legal practice including federal agency deference, noncompetition agreements, overtime exemptions ...
At age 50, MD nonprofit's National History Day keeps pushing students to seek difficult truths -...
The Daily Record· 6 days agoHigh school freshman Alexandra Bui constructed a jumbo mail-order catalog replica from wooden sheets...
Tam Hoang To Teach New Ethnic Literature Course At CHS
Coronado Eagle & Journal· 6 days agoDuring the January 18 Coronado Unified School District board meeting, Assembly Bill 101 was presented and discussed at length. AB101 has added Ethnic Studies to the list of high school graduation ...
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF...
Benzinga· 3 days agoClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero ...
Antibiotic Delays in ED Triple Sepsis Deaths in Children
Medscape· 6 days agoDelays in antibiotic administration increased the mortality risk by threefold in children with...
AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
Morningstar· 5 days agoLOS ANGELES, June 18, 2024 /PRNewswire/ -- , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ: AKRO) for violations of §§10(b) and 20(a) of
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy...
Morningstar· 4 days agoAurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001 First allogeneic cell therapy to receive both FDA ...
